Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Stimuli-Activated

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...

Modified-Release Drug Delivery Systems: Classification

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Transdermal Drug Delivery Systems

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Macroscopic Convective Fluid Flows Arising From Binding of Ions and Small Molecules to Proteins.

Small (Weinheim an der Bergstrasse, Germany)·2026

Same author

Emergent Nonlinearity in Active Molecular Chemotaxis.

ACS nano·2026

Same author

Fibroblast Growth Factor Receptor Signaling in Maturing Osteoblasts Controls Cell-Matrix Interactions Critical for Osteocyte Survival.

bioRxiv : the preprint server for biology·2026

Same author

Chemotaxis of ATPase-Powered Nanoparticles up Extra- and Intracellular ATP Gradients.

Nano letters·2026

Same author

Programmable dendritic systems for active fluidics and motility.

Chemical communications (Cambridge, England)·2026

Same author

Palladium on S,N-containing carbon materials derived from covalent triazine-based frameworks (CTFs) for C-C coupling and electrocatalytic hydrogen production.

Nanoscale·2026

Search research articles

Related Experiment Video

Updated: May 16, 2026

High Speed Droplet-based Delivery System for Passive Pumping in Microfluidic Devices

High Speed Droplet-based Delivery System for Passive Pumping in Microfluidic Devices

Published on: September 2, 2009

Intelligent, self-powered, drug delivery systems.

Debabrata Patra¹, Samudra Sengupta, Wentao Duan

¹Department of Chemistry, Pennsylvania State University, University Park, PA 16802, USA.

|November 21, 2012

Summary

This summary is machine-generated.

Intelligent nano/micromotors and pumps offer advanced drug delivery by self-propelling or being guided to targets. These synthetic machines represent a promising future for precise cargo transport in biomedical applications.

More Related Videos

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

Microinjectrode System for Combined Drug Infusion and Electrophysiology

Microinjectrode System for Combined Drug Infusion and Electrophysiology

Published on: November 13, 2019

Related Experiment Videos

Last Updated: May 16, 2026

High Speed Droplet-based Delivery System for Passive Pumping in Microfluidic Devices

High Speed Droplet-based Delivery System for Passive Pumping in Microfluidic Devices

Published on: September 2, 2009

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

Microinjectrode System for Combined Drug Infusion and Electrophysiology

Microinjectrode System for Combined Drug Infusion and Electrophysiology

Published on: November 13, 2019

Area of Science:

Biomedical Engineering
Nanotechnology
Materials Science

Background:

Self-propelled nano/micromotors and pumps are emerging as advanced drug delivery systems.
These systems can autonomously navigate or be guided to specific biological targets.
Recent progress has focused on developing these nano/microtransporters for practical biomedical uses.

Purpose of the Study:

To review the advancements in the design of synthetic nano/micromotors and pumps.
To highlight their capabilities in cargo transportation and targeted delivery.
To discuss the potential of these intelligent machines in future medical applications.

Main Methods:

Literature review of synthetic nano/micromotors and pumps.
Analysis of design principles for propulsion and cargo loading.
Evaluation of targeted delivery strategies based on biomarkers.

Main Results:

Significant progress in the design of nano/micromotors and pumps for biomedical applications.
Demonstration of proof-of-concept tools for cargo transport and targeted delivery.
Development of systems responding to specific biomarkers for enhanced precision.

Conclusions:

Synthetic nano/micromotors and pumps show great promise for next-generation drug delivery.
Intelligent machines capable of navigating the human body are on the horizon.
Further development could lead to revolutionary in-body diagnostic and therapeutic capabilities.